强效降糖、安全达标-CSII治疗糖尿病长期患者模板.ppt

* 多中心随机平行对照研究. Raskin研究中，132例从未接受过CSII治疗的2型糖尿患者（糖尿病诊断2年，使用胰岛素治疗6个月，A1C7.5%），随机分为2组，分别接受CSII和MDI治疗24周。患者生活质量以PHASE V Tech nologies Outcomes Information System 进行评估.CSII组与MDI组相比，生活质量显著提高. * Erin: so why the MDT Revel for Type 2?.. Matt: Because the Revel meets the unique needs of the Type 2 patient. For instance, the Revel has the option of setting the Insulin to Carb Ratio at 1:1… … PLUS the convenience of the 300 unit reservoir… ERIN: and the missed meal bolus reminder – which definitely helps improve outcomes, however we will highlight this when we overcome the compliance objections… al